Walgreens Boots Alliance, Inc. Overview
Pro stress-test →Walgreens Boots Alliance, Inc. (WBA) was an American multinational holding company headquartered in Deerfield, Illinois. In March 2025, the company agreed to be taken private by Sycamore Partners for $10 billion, with the acquisition completed in August 2025, after which WBA was split into five companies: Walgreens, The Boots Group, VillageMD, CareCentrix and Shields Health Solutions. As of June 2026, the entity's trailing twelve-month revenue was $154.58 billion.
Strategic Profile
Pro stress-test →Walgreens Boots Alliance was an integrated healthcare, pharmacy and retail company in the pharmacies and drug stores industry. Post-privatization challenges include debt management in a higher-rate environment, opioid litigation settlements paid over several years, and retail theft pressures in urban stores. Sycamore Partners is expected to list Boots UK on the London Stock Exchange in late 2026 or 2027, as Boots remains a highly profitable brand in the UK.
Competitive Landscape
Pro stress-test →Walgreens Boots Alliance operated across U.S. Retail Pharmacy, International, and U.S. Healthcare segments, with U.S. retail drugstores, specialty pharmacy, health and wellness services, and international pharmacy-led retail under Boots (UK, Ireland, Thailand), Benavides (Mexico), and Ahumada (Chile) brands. Primary competitors include CVS Health, Rite Aid, Amazon Pharmacy, and independent pharmacy networks; internationally, Boots competes with Lloyds Pharmacy and regional players in its operating markets.
Industry Context
Walgreens Boots Alliance, Inc. operates in Pharmacy retail and health services distribution.
Key facts
Founded: 2014 (as merged entity; Walgreens founded 1901) · Headquarters: Deerfield, Illinois, US · Employees: N/A · Revenue: $154.58B (TTM as of June 2026) · Market cap: N/A